Latest Breaking News On - Primary biliary cholangitis - Page 11 : comparemela.com

Stonegate Healthcare Partners Releases Report on Transformative | The Kingston Whig Standard

Dallas, Texas (Newsfile Corp. - November 30, 2023) - Stonegate Healthcare Partners is pleased to announce the publication of its latest

Stonegate Healthcare Partners Releases Report on Transformative Therapies for Pruritus Management

Genfit: Large PBC Market, Liquidity To Await Approval (NASDAQ:GNFT)

Q&A: The Microbiome and Autoimmune Liver Disease, with Gideon Hirschfield, PhD, MB BChir

Gideon Hirschfield, PhD, MB BChir, Lily and Terry Horner Chair in Autoimmune Liver Disease Research at the University of Toronto, sat down with HCPLive Hepatology to discuss the role of the microbiome in autoimmune liver disease.

#VisualAbstract: Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis

Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.